A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 2,617,713 shares of DAWN stock, worth $33.2 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
2,617,713
Previous 2,923,137 10.45%
Holding current value
$33.2 Million
Previous $40.3 Million 9.47%
% of portfolio
0.68%
Previous 0.85%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$12.72 - $16.03 $3.88 Million - $4.9 Million
-305,424 Reduced 10.45%
2,617,713 $36.5 Million
Q2 2024

Aug 14, 2024

BUY
$12.03 - $17.69 $13.9 Million - $20.5 Million
1,157,825 Added 65.59%
2,923,137 $40.3 Million
Q1 2024

May 15, 2024

BUY
$13.56 - $17.46 $56,057 - $72,179
4,134 Added 0.23%
1,765,312 $29.2 Million
Q4 2023

Feb 14, 2024

BUY
$9.68 - $15.37 $4.75 Million - $7.55 Million
491,186 Added 38.68%
1,761,178 $25.7 Million
Q2 2023

Aug 14, 2023

BUY
$11.74 - $14.47 $14.9 Million - $18.4 Million
1,269,992 New
1,269,992 $15.2 Million
Q4 2022

Feb 14, 2023

SELL
$18.77 - $22.0 $1.28 Million - $1.5 Million
-67,967 Reduced 6.59%
964,033 $20.7 Million
Q3 2022

Nov 14, 2022

SELL
$16.44 - $26.57 $40.8 Million - $65.9 Million
-2,480,123 Reduced 70.62%
1,032,000 $20.7 Million
Q2 2022

Aug 15, 2022

BUY
$5.72 - $17.9 $8.15 Million - $25.5 Million
1,425,674 Added 68.33%
3,512,123 $62.9 Million
Q1 2022

May 16, 2022

SELL
$9.12 - $17.47 $1.06 Million - $2.03 Million
-116,084 Reduced 5.27%
2,086,449 $20.7 Million
Q4 2021

Feb 14, 2022

BUY
$15.65 - $26.33 $7.7 Million - $12.9 Million
491,803 Added 28.75%
2,202,533 $37.1 Million
Q3 2021

Nov 15, 2021

BUY
$20.0 - $27.92 $17.8 Million - $24.9 Million
891,750 Added 108.89%
1,710,730 $40.6 Million
Q2 2021

Aug 16, 2021

BUY
$19.0 - $23.69 $15.6 Million - $19.4 Million
818,980 New
818,980 $18.6 Million

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $931M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.